Rein Therapeutics Files 2024 Annual Report Amendment
Ticker: RNTX · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 1420565
| Field | Detail |
|---|---|
| Company | Rein Therapeutics, Inc. (RNTX) |
| Form Type | 10-K/A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceutical
TL;DR
Rein Therapeutics amended its 2024 10-K filing on April 30, 2025.
AI Summary
Rein Therapeutics, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly known as Aileron Therapeutics, Inc., is a pharmaceutical preparations company based in Austin, TX. This amendment was filed on April 30, 2025, and pertains to the fiscal year ending December 31, 2024.
Why It Matters
This filing provides updated information for the fiscal year 2024, which is crucial for investors to assess the company's financial health and strategic direction.
Risk Assessment
Risk Level: low — This is an amendment to an annual report, not a new filing with significant new disclosures.
Key Numbers
- 2024 — Fiscal Year End (The annual report covers the fiscal year ending December 31, 2024.)
- 20250430 — Filing Date (This amendment to the 10-K was filed on April 30, 2025.)
Key Players & Entities
- Rein Therapeutics, Inc. (company) — Registrant
- Aileron Therapeutics, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 20250430 (date) — Filing date
- Austin, TX (location) — Business address
FAQ
What is the primary purpose of this 10-K/A filing?
This 10-K/A filing is an amendment to Rein Therapeutics, Inc.'s annual report for the fiscal year ended December 31, 2024.
When was this amendment filed with the SEC?
This amendment was filed on April 30, 2025.
What was Rein Therapeutics, Inc. formerly known as?
Rein Therapeutics, Inc. was formerly known as Aileron Therapeutics, Inc.
What is the company's primary business sector?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
Where is Rein Therapeutics, Inc. located?
Rein Therapeutics, Inc. is located at 12407 N. Mopac Expy., Suite 250 #390, Austin, TX 78758.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding Rein Therapeutics, Inc. (RNTX).